Health and economic impact of combining metformin with nateglinide to achieve glycemic control: Comparison of the lifetime costs of complications in the U.K
-
* Corresponding author: Alexandra J Ward alexward@caroresearch.com
Cost Effectiveness and Resource Allocation 2004, 2:2 doi:10.1186/1478-7547-2-2
No comments have yet been made on this article.